Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study.


Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 11 2 2021
medline: 23 11 2021
entrez: 10 2 2021
Statut: ppublish

Résumé

It is uncertain if long-term levels of low-density lipoprotein-cholesterol (LDL-C) affect cognition in middle age. We examined the association of LDL-C levels over 25 years with cognitive function in a prospective cohort of black and white US adults. Lipids were measured at baseline (1985-1986; age: 18-30 years) and at serial examinations conducted over 25 years. Time-averaged cumulative LDL-C was calculated using the area under the curve for 3,328 participants with ≥3 LDL-C measurements and a cognitive function assessment. Cognitive function was assessed at the Year 25 examination with the Digit Symbol Substitution Test [DSST], Rey Auditory Visual Learning Test [RAVLT], and Stroop Test. A brain magnetic resonance imaging (MRI) sub-study (N = 707) was also completed at Year 25 to assess abnormal white matter tissue volume (AWMV) and gray matter cerebral blood flow volume (GM-CBFV) as secondary outcomes. There were 15.6%, 32.9%, 28.9%, and 22.6% participants with time-averaged cumulative LDL-C <100 mg/dL, 101-129 mg/dL, 130-159 mg/dL, and ≥160 mg/dL, respectively. Standardized differences in all cognitive function test scores ranged from 0.16 SD lower to 0.09 SD higher across time-averaged LDL-C categories in comparison to those with LDL-C < 100 mg/dL. After covariate adjustment, participants with higher versus lower time-averaged LDL-C had a lower RAVLT score (p-trend = 0.02) but no differences were present for DSST, Stroop Test, AWMV, or GM-CBFV. Cumulative LDL-C was associated with small differences in memory, as assessed by RAVLT scores, but not other cognitive or brain MRI measures over 25 years of follow-up.

Identifiants

pubmed: 33563358
pii: S1355617721000059
doi: 10.1017/S1355617721000059
pmc: PMC8353005
mid: NIHMS1662616
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1048-1057

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201300026C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201300025C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States

Références

J Am Heart Assoc. 2017 May 18;6(5):
pubmed: 28522676
Neuropsychology. 2000 Apr;14(2):224-32
pubmed: 10791862
N Engl J Med. 2017 Aug 17;377(7):633-643
pubmed: 28813214
Neurology. 2015 Jun 9;84(23):2347-53
pubmed: 25957331
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Hum Brain Mapp. 2013 Aug;34(8):1826-41
pubmed: 22438182
Soc Psychiatry Psychiatr Epidemiol. 2005 Jul;40(7):557-63
pubmed: 16021346
Tohoku J Exp Med. 2004 Dec;204(4):299-308
pubmed: 15572855
J Am Coll Cardiol. 2017 Feb 7;69(5):471-482
pubmed: 28153102
N Engl J Med. 2015 Apr 16;372(16):1500-9
pubmed: 25773607
J Clin Exp Neuropsychol. 2012;34(2):220-5
pubmed: 22149630
Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):e38-e81
pubmed: 30580575
Clin Chem. 2005 Jan;51(1):125-31
pubmed: 15514100
Circulation. 2014 Apr 15;129(15):1560-7
pubmed: 24687777
Lancet. 2012 Aug 11;380(9841):581-90
pubmed: 22607822
N Engl J Med. 2015 Apr 16;372(16):1489-99
pubmed: 25773378
Circulation. 2018 Mar 20;137(12):1260-1269
pubmed: 29146683
Curr Med Res Opin. 2005;21 Suppl 6:S9-16
pubmed: 16138936
Clin Chem. 1994 Jan;40(1):11-3
pubmed: 8287516
Clin Infect Dis. 2016 Oct 15;63(8):1130-1139
pubmed: 27448678
JAMA. 2007 Sep 19;298(11):1300-11
pubmed: 17878422
Drug Saf. 2015 Jun;38(6):519-26
pubmed: 25989944
Neurosci Biobehav Rev. 2010 Jul;34(8):1366-79
pubmed: 20470821
JAMA. 2013 Nov 20;310(19):2061-8
pubmed: 24240933
J Int Neuropsychol Soc. 2020 Mar;26(3):251-262
pubmed: 31543086
Am J Public Health. 2007 Apr;97(4):703-9
pubmed: 17329668
Biochim Biophys Acta. 2012 Mar;1822(3):361-9
pubmed: 21889590
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Am J Geriatr Psychiatry. 2008 Sep;16(9):781-5
pubmed: 18757771
Lancet. 2002 Jul 6;360(9326):7-22
pubmed: 12114036
Lancet. 2002 Nov 23;360(9346):1623-30
pubmed: 12457784
Mol Aspects Med. 2009 Jun;30(3):171-9
pubmed: 19248803
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
J Cardiopulm Rehabil. 1989 Nov;9(11):448-459
pubmed: 29657358
Arch Neurol. 2011 Nov;68(11):1385-92
pubmed: 22084122
PLoS One. 2013 May 22;8(5):e65228
pubmed: 23717695
J Am Coll Cardiol. 2020 May 12;75(18):2283-2293
pubmed: 32381158
Ann Intern Med. 2010 Aug 3;153(3):137-46
pubmed: 20679558
JAMA Intern Med. 2014 Mar;174(3):324-33
pubmed: 24493100
Dement Geriatr Cogn Disord. 2010;29(3):240-7
pubmed: 20375504
PLoS One. 2015 Mar 26;10(3):e0122138
pubmed: 25812012
BMJ. 2017 Apr 24;357:j1648
pubmed: 28438747
Arch Neurol. 2004 May;61(5):705-14
pubmed: 15148148
Curr Atheroscler Rep. 2013 Mar;15(3):307
pubmed: 23328907
Circulation. 1997 Nov 18;96(10):3287-93
pubmed: 9396418
Age (Dordr). 2014;36(4):9673
pubmed: 25073452
Methods Mol Med. 2005;108:159-72
pubmed: 16028683
Neurology. 2011 Aug 2;77(5):461-8
pubmed: 21810696
Mol Psychiatry. 2012 Mar;17(3):315-24
pubmed: 21263443

Auteurs

Matthew T Mefford (MT)

University of Alabama at Birmingham, Birmingham, AL, USA.

Ligong Chen (L)

University of Alabama at Birmingham, Birmingham, AL, USA.

Cora E Lewis (CE)

University of Alabama at Birmingham, Birmingham, AL, USA.

Paul Muntner (P)

University of Alabama at Birmingham, Birmingham, AL, USA.

Stephen Sidney (S)

Kaiser Permanente Division of Research, Oakland, CA, USA.

Lenore J Launer (LJ)

Intramural Research Program, National Institute on Aging, Bethesda, MD, USA.

Keri L Monda (KL)

Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA.

Andrea Ruzza (A)

Global Clinical Development, Cardiovascular and Metabolic Therapeutic Area, Amgen Inc., Thousand Oaks, CA, USA.

Helina Kassahun (H)

Global Clinical Development, Cardiovascular and Metabolic Therapeutic Area, Amgen Inc., Thousand Oaks, CA, USA.

Robert S Rosenson (RS)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

April P Carson (AP)

University of Alabama at Birmingham, Birmingham, AL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH